Natera (NTRA) Operating Leases (2019 - 2026)
Natera's (NTRA) quarterly Operating Leases came in at $158.2 million in Q2 2026, up 53.98% on a YoY basis from $102.7 million in Q2 2025, and down 0.99% quarter-over-quarter from $159.8 million in Q1 2026.
Analysis
Natera (NTRA) Operating Leases (2019 - 2026) Analysis & Trends
Natera (NTRA) has reported Operating Leases for 8 consecutive years, with $158.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Leases rose 53.98% year-over-year to $158.2 million; the trailing twelve-month figure through Jun 2026 stood at $158.2 million (up 53.98% YoY), and the FY2025 full-year result was $134.1 million, up 38.79% from the prior year.
- Operating Leases declined to $158.2 million in Q2 2026 per NTRA's latest filing, from $159.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $159.8 million in Q1 2026 and bottomed at $61.2 million in Q2 2024.
- Historically, Operating Leases has averaged $91.7 million across 5 years, with a median of $77.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Operating Leases fell 13.88% in 2024, then jumped 67.81% in 2025.
- Over 5 years, Operating Leases stood at $76.6 million in 2022, then declined by 12.47% to $67.0 million in 2023, then jumped by 44.11% to $96.6 million in 2024, then jumped by 38.79% to $134.1 million in 2025, then gained by 18.01% to $158.2 million in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $158.2 million, $159.8 million, and $134.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 158.20 Mn |
| Mar 31, 2026 | 159.78 Mn |
| Dec 31, 2025 | 134.05 Mn |
| Sep 30, 2025 | 104.38 Mn |
| Jun 30, 2025 | 102.74 Mn |
| Mar 31, 2025 | 103.06 Mn |
| Dec 31, 2024 | 96.59 Mn |
| Sep 30, 2024 | 98.95 Mn |
| Jun 30, 2024 | 61.23 Mn |
| Mar 31, 2024 | 64.16 Mn |
| Dec 31, 2023 | 67.03 Mn |
| Sep 30, 2023 | 68.29 Mn |
| Jun 30, 2023 | 71.09 Mn |
| Mar 31, 2023 | 73.85 Mn |
| Dec 31, 2022 | 76.58 Mn |
| Sep 30, 2022 | 78.47 Mn |
| Jun 30, 2022 | 65.42 Mn |
| Mar 31, 2022 | 67.48 Mn |
| Dec 31, 2021 | 61.04 Mn |
| Sep 30, 2021 | 48.39 Mn |